Porous freeze-dried structure containing pollen polysaccharides

TWM689463UActive Publication Date: 2026-11-11BENEFIT TECHNIQUE CONSULTING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115204278
Authority / Receiving Office
TW · TW
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-05-13
Publication Date
2026-11-11
Estimated Expiration
2036-05-12

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

This invention provides a porous freeze-dried structure containing pollen polysaccharides, comprising a polysaccharide layer, a plurality of pollen polysaccharide particles encapsulated within the polysaccharide layer, and a porous layer encapsulating the polysaccharide layer to form a porous freeze-dried structure. It inhibits the activation of pro-inflammatory M1 macrophages, guides monocytes to strategically polarize into alternative M2 macrophages, promotes the transition of physiological states from the inflammatory stage to the tissue remodeling stage, and provides a potent antipruritic effect.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A porous freeze-dried structure containing pollen polysaccharides, comprising a polysaccharide layer, a plurality of pollen polysaccharide particles encapsulated within the polysaccharide layer, and a porous layer encapsulating the polysaccharide layer to form a porous freeze-dried structure.

2. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the polysaccharide layer comprises a rhamnose galacturon polysaccharide I (RG-I) having β-galactan and / or α-arabinan side chains.

3. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the porous layer comprises D-glucopyranoses, xyloglucans, α-glucan, and β-glucan to provide rheological consistency and structural porosity of the freeze-dried scaffold.

4. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the thickness of the porous freeze-dried structure containing pollen polysaccharides is 1 to 20 mm.

5. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the pore size of the porous layer is 10 to 200 mm.

6. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the porous freeze-dried structure containing pollen polysaccharides can inhibit the activation of pro-inflammatory M1 macrophages and guide monocytes to strategically polarize into alternative M2 macrophages.

7. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, wherein the porous freeze-dried structure containing pollen polysaccharides can regulate the innate immune response and promote the transition of the physiological state from the inflammatory stage to the tissue remodeling stage.

8. The porous freeze-dried structure containing pollen polysaccharides as described in claim 1, which can stabilize the microenvironment around the sensory nerve endings of the skin, thereby increasing the threshold of itch signal transduction and providing a strong anti-itch (antipruritic) effect.